Department of Orthopaedic Surgery, Keio University School of Medicine, 35 Shinanomachi, Shinjuku, Tokyo, 160-8582, Japan.
Mol Brain. 2013 Jan 8;6:3. doi: 10.1186/1756-6606-6-3.
The transplantation of neural stem/progenitor cells (NS/PCs) at the sub-acute phase of spinal cord injury, but not at the chronic phase, can promote functional recovery. However, the reasons for this difference and whether it involves the survival and/or fate of grafted cells under these two conditions remain unclear. To address this question, NS/PC transplantation was performed after contusive spinal cord injury in adult mice at the sub-acute and chronic phases.
Quantitative analyses using bio-imaging, which can noninvasively detect surviving grafted cells in living animals, revealed no significant difference in the survival rate of grafted cells between the sub-acute and chronic transplantation groups. Additionally, immunohistology revealed no significant difference in the differentiation phenotypes of grafted cells between the two groups. Microarray analysis revealed no significant differences in the expression of genes encoding inflammatory cytokines or growth factors, which affect the survival and/or fate of grafted cells, in the injured spinal cord between the sub-acute and chronic phases. By contrast, the distribution of chronically grafted NS/PCs was restricted compared to NS/PCs grafted at the sub-acute phase because a more prominent glial scar located around the lesion epicenter enclosed the grafted cells. Furthermore, microarray and histological analysis revealed that the infiltration of macrophages, especially M2 macrophages, which have anti-inflammatory role, was significantly higher at the sub-acute phase than the chronic phase. Ultimately, NS/PCs that were transplanted in the sub-acute phase, but not the chronic phase, promoted functional recovery compared with the vehicle control group.
The extent of glial scar formation and the characteristics of inflammation is the most remarkable difference in the injured spinal cord microenvironment between the sub-acute and chronic phases. To achieve functional recovery by NS/PC transplantation in cases at the chronic phase, modification of the microenvironment of the injured spinal cord focusing on glial scar formation and inflammatory phenotype should be considered.
在脊髓损伤的亚急性期而非慢性期移植神经干细胞/祖细胞(NS/PCs)可以促进功能恢复。然而,造成这种差异的原因以及这种差异是否涉及这两种情况下移植细胞的存活和/或命运尚不清楚。为了回答这个问题,我们在成年小鼠脊髓损伤的亚急性期和慢性期进行了 NS/PC 移植。
使用生物成像进行的定量分析可以无创地检测活体动物中存活的移植细胞,结果显示亚急性期和慢性期移植组移植细胞的存活率没有显著差异。此外,免疫组织化学显示两组移植细胞的分化表型没有显著差异。微阵列分析显示,在亚急性期和慢性期之间,损伤脊髓中影响移植细胞存活和/或命运的炎性细胞因子或生长因子的基因表达没有显著差异。相比之下,与亚急性期移植的 NS/PC 相比,慢性期移植的 NS/PC 分布受到限制,因为位于损伤中心周围的更明显的胶质瘢痕包围了移植细胞。此外,微阵列和组织学分析显示,巨噬细胞(尤其是具有抗炎作用的 M2 巨噬细胞)的浸润在亚急性期明显高于慢性期。最终,与载体对照组相比,在亚急性期而非慢性期移植的 NS/PC 促进了功能恢复。
在亚急性期和慢性期之间,损伤脊髓微环境中胶质瘢痕形成和炎症特征的程度是最显著的差异。为了在慢性期通过 NS/PC 移植实现功能恢复,应考虑针对损伤脊髓的微环境,重点是胶质瘢痕形成和炎症表型的修饰。